人类心脏中信号传导通路的差异激活高与先进心力衰竭相比
1Cardiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Circulation
|February 7, 2001
概括
在心脏衰竭期间,心脏信号通路在心脏中发生变化. 虽然过度缩小显示了氨酸的优势,但失败的心脏激活了线粒激活蛋白激酶 (MAPK) 和Akt/糖原合成酶激酶-3 (GSK-3),可能会影响心力衰竭的进展.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 细胞信号传递 细胞信号传递
背景情况:
- 左心室衰竭通常跟随心脏缩.
- 像MAPKs,Akt/GSK-3和calcineurin这样的信号通路都与缩和亡有关.
- 了解这些途径对于心力衰竭机制至关重要.
研究的目的:
- 调查人类心力衰竭和缩中关键信号通路的活性.
- 为了比较补偿性缩和晚期心力衰竭之间的信号概况.
主要方法:
- 对心脏组织中信号通路活动的分析,从患有晚期心力衰竭,补偿心脏缩和正常受试者的患者.
- 评估了线粒激素激活蛋白激酶 (MAPKs),Akt,糖原合成酶激酶-3 (GSK-3) 和氨酸的活性.
主要成果:
- 在缩中,氨酸是主导的激活途径;MAPKs和Akt/GSK-3没有被激活.
- 在失败的心脏中,氨酸活性增加,但MAPKs和Akt被激活,导致GSK-3抑制.
- 这些路径激活发生不论心肌病的原因 (缺血性或异常性).
结论:
- 失败的心脏表现出一种益高缩的信号特征,可能是由于压力和神经激素因素.
- 过度缩途径的激活可以产生既有前的,也有反的信号.
- 调节这些信号通路为心力衰竭进展提供了潜在的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Heart Failure I: Introduction
1.4K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Heart Failure II: Pathophysiology
1.6K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Heart Failure IV: Classification and Diagnostic Evaluation
836
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
836
Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cellular Adaptation II: Hypertrophy
37
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
37


